Log In
Print
BCIQ
Print
Print this Print this
 

BCX4161

  Manage Alerts
Collapse Summary General Information
Company BioCryst Pharmaceuticals Inc.
DescriptionInhibits plasma kallikrein and suppresses bradykinin production
Molecular Target Kallikrein
Mechanism of ActionKallikrein inhibitor
Latest Stage of DevelopmentPhase I
IndicationAngioedema
Partner

 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today